Glucose intolerance induced by glucocorticoid excess is further impaired by co-administration with β-hydroxy-β-methylbutyrate in rats

Applied Physiology, Nutrition and Metabolism

Volumn 38, Issue 11, 2013, Pages 1137-1146

  Nunes, Everson A ^a   Gonçalves Neto, Luiz M ^a   Ferreira, Francielle B D ^a   dos Santos, Cristiane ^a   Fernandes, Luiz C ^b   Boschero, Antonio C ^c   Calder, Philip C ^d   Rafacho, Alex ^a  

^a FEDERAL UNIVERSITY OF SANTA CATARINA   (Brazil)

^b FEDERAL UNIVERSITY OF PARANÁ   (Brazil)

^c UNIVERSITY OF CAMPINAS   (Brazil)

^d UNIVERSITY OF SOUTHAMPTON   (United Kingdom)

Author keywords

hydroxy methylbutyrate (HMB); Dexamethasone; Glucocorticoid; Glucose tolerance; Insulin sensitivity; Metabolism; Supplementation

Indexed keywords

GLUCOSE BLOOD LEVEL;

ANIMAL; BODY WEIGHT; DRUG EFFECTS; GLUCOSE BLOOD LEVEL; GLUCOSE INTOLERANCE; HUMAN; INSULIN RESISTANCE; METABOLISM; MUSCLE ATROPHY; RAT; WISTAR RAT;

ANIMALS; BLOOD GLUCOSE; BODY WEIGHT; GLUCOSE INTOLERANCE; HUMANS; INSULIN RESISTANCE; MUSCULAR ATROPHY; RATS; RATS, WISTAR;

EID: 84884478456     PISSN: 17155312     EISSN: 17155320     Source Type: Journal    
DOI: 10.1139/apnm-2012-0456     Document Type: Article

References (45)

1. Andrews, A.L., Wong, K.A., Heine, D., and Scott Russell, W. 2012. A costeffectiveness analysis of dexamethasone versus prednisone in pediatric acute asthma exacerbations. Acad. Emerg. Med. 19(8): 943-948. doi:10.1111/j.1553-2712.2012.01418.x. PMID:22849379.
2. Aversa, Z., Alamdari, N., Castillero, E., Muscaritoli, M., Rossi Fanelli, F., and Hasselgren, P.O. 2012. β-Hydroxy- β-methylbutyrate (HMB) prevents dexamethasone-induced myotube atrophy. Biochem. Biophys. Res. Commun. 423(4): 739-743. doi:10.1016/j.bbrc.2012.06.029. PMID:22705301.
3. Balage, M., Dupont, J., Mothe-Satney, I., Tesseraud, S., Mosoni, L., and Dardevet, D. 2011. Leucine supplementation in rats induced a delay in muscle IR/PI3K signaling pathway associated with overall impaired glucose tolerance. J. Nutr. Biochem. 22(3): 219-226. doi:10.1016/j.jnutbio.2010.02.001. PMID:20558053.
4. Baxter, J.H., Carlos, J.L., Thurmond, J., Rehani, R.N., Bultman, J., and Frost, D. 2005. Dietary toxicity of calcium beta-hydroxy-beta-methyl butyrate (CaHMB). Food Chem. Toxicol. 43(12): 1731-1741. doi:10.1016/j.fct.2005.05.016. PMID: 16006030.
5. Berk, L., James, J., Schwartz, A., Hug, E., Mahadevan, A., Samuels, M., et al. 2008. A randomized, double-blind, placebo-controlled trial of a beta-hydroxyl betamethyl butyrate, glutamine, and arginine mixture for the treatment of cancer cachexia (RTOG 0122). Support Care Cancer, 16(10): 1179-1188. doi:10.1007/s00520-008-0403-7. PMID:18293016.
6. Breitman, I., Saraf, N., Kakade, M., Yellumahanthi, K., White, M., Hackett, J.A., et al. 2011. The effects of an amino acid supplement on glucose homeostasis, inflammatory markers, and incretins after laparoscopic gastric bypass. J. Am. Coll. Surg. 212(4): 617-627. doi:10.1016/j.jamcollsurg.2010.12.040. PMID:21463799.
7. Bucolo, G., and David, H. 1973. Quantitative determination of serum triglycerides by the use of enzymes. Clin. Chem. 19(5): 476-482. PMID:4703655.
8. Caperuto, E.C., Tomatieli, R.V., Colquhoun, A., Seelaender, M.C., and Costa Rosa, L.F. 2007. Beta-hydoxy-beta-methylbutyrate supplementation affects Walker 256 tumor-bearing rats in a time-dependent manner. Clin. Nutr. 26(1): 117-122. doi:10.1016/j.clnu.2006.05.007. PMID:17011676.
9. Eley, H.L., Russell, S.T., Baxter, J.H., Mukerji, P., and Tisdale, M.J. 2007. Signaling pathways initiated by beta-hydroxy-beta-methylbutyrate to attenuate the depression of protein synthesis in skeletal muscle in response to cachectic stimuli. Am. J. Physiol. Endocrinol. Metab. 293(4): E923-E931. doi:10.1152/ajpendo.00314.2007. PMID:17609254.
10. Fleseriu, M., and Petersenn, S. 2012. Medical management of Cushing's disease: what is the future? Pituitary, 15(3): 330-341. doi:10.1007/s11102-012-0397-5. PMID:22674211.
11. Gerlinger-Romero, F., Guimaraes-Ferreira, L., Giannocco, G., and Nunes, M.T. 2011. Chronic supplementation of beta-hydroxy-beta methylbutyrate (HMbeta) increases the activity of the GH/IGF-I axis and induces hyperinsulinemia in rats. Growth Horm. IGF Res. 21(2): 57-62. doi:10.1016/j.ghir.2010.12.006. PMID:21237681.
12. Giozzet, V.A., Rafacho, A., Boschero, A.C., Carneiro, E.M., and Bosqueiro, J.R. 2008. Dexamethasone treatment in vivo counteracts the functional pancreatic islet alterations caused by malnourishment in rats. Metabolism, 57(5): 617-624. doi:10.1016/j.metabol.2007.12.004. PMID:18442623.
13. Guerrero-Romero, F., Simental-Mendia, L.E., Gonzalez-Ortiz, M., Martinez-Abundis, E., Ramos-Zavala, M.G., Hernandez-Gonzalez, S.O., et al. 2010. The product of triglycerides and glucose, a simple measure of insulin sensitivity. Comparison with the euglycemic-hyperinsulinemic clamp. J. Clin. Endocrinol. Metab. 95(7): 3347-3351. doi:10.1210/jc.2010-0288. PMID:20484475.
14. Jocken, J.W., and Blaak, E.E. 2008. Catecholamine-induced lipolysis in adipose tissue and skeletal muscle in obesity. Physiol. Behav. 94(2): 219-230. doi:10.1016/j.physbeh.2008.01.002. PMID:18262211.
15. Katz, A., Nambi, S.S., Mather, K., Baron, A.D., Follmann, D.A., Sullivan, G., et al. 2000. Quantitative insulin sensitivity check index: a simple, accurate method for assessing insulin sensitivity in humans. J. Clin. Endocrinol. Metab. 85(7): 2402-2410. doi:10.1210/jc.85.7.2402. PMID:10902785.
16. Kelly, H.W., Sternberg, A.L., Lescher, R., Fuhlbrigge, A.L., Williams, P., Zeiger, R.S., et al. 2012. Effect of inhaled glucocorticoids in childhood on adult height. N. Engl. J. Med. 367(10): 904-912. doi:10.1056/NEJMoa1203229. PMID:22938716.
17. Kovarik, M., Muthny, T., Sispera, L., and Holecek, M. 2010. Effects of betahydroxy-beta-methylbutyrate treatment in different types of skeletal muscle of intact and septic rats. J. Physiol. Biochem. 66(4): 311-319. doi:10.1007/s13105-010-0037-3. PMID:20725872.
18. Kuczera, D., Paro de Oliveira, H.H., Fonseca Guimaraes Fde, S., de Lima, C., Alves, L., Machado, A.F., et al. 2012. Bax/Bcl-2 protein expression ratio and leukocyte function are related to reduction of Walker-256 tumor growth after beta-hydroxy-beta-methylbutyrate (HMB) administration in Wistar rats. Nutr. Cancer, 64(2): 286-293. doi:10.1080/01635581.2012.647229. PMID: 22242972.
19. Lafontan, M., and Langin, D. 2009. Lipolysis and lipid mobilization in human adipose tissue. Prog. Lipid Res. 48(5): 275-297. doi:10.1016/j.plipres.2009.05.001. PMID:19464318.
20. Lo, S., Russell, J.C., and Taylor, A.W. 1970. Determination of glycogen in small tissue samples. J. Appl. Physiol. 28(2): 234-236. PMID:5413312.
21. Matthews, D.R., Hosker, J.P., Rudenski, A.S., Naylor, B.A., Treacher, D.F., and Turner, R.C. 1985. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia, 28(7): 412-419. doi:10.1007/BF00280883. PMID:3899825.
22. Møller, N., and Jørgensen, J.O. 2009. Effects of growth hormone on glucose, lipid, and protein metabolism in human subjects. Endocr. Rev. 30(2): 152-177. doi: 10.1210/er.2008-0027. PMID:19240267.
23. Nicod, N., Giusti, V., Besse, C., and Tappy, L. 2003. Metabolic adaptations to dexamethasone-induced insulin resistance in healthy volunteers. Obes. Res. 11(5): 625-631. doi:10.1038/oby.2003.90. PMID:12740452.
24. Nissen, S., Sharp, R.L., Panton, L., Vukovich, M., Trappe, S., and Fuller, J.C., Jr. 2000. beta-hydroxy-beta-methylbutyrate (HMB) supplementation in humans is safe and may decrease cardiovascular risk factors. J. Nutr. 130(8): 1937-1945. PMID:10917905.
25. Novelli, M., De Tata, V., Bombara, M., Lorenzini, A., Masini, M., Pollera, M., et al. 1999. Insufficient adaptive capability of pancreatic endocrine function in dexamethasone-treated ageing rats. J. Endocrinol. 162(3): 425-432. doi:10.1677/joe.0.1620425. PMID:10467234.
26. Nunes, E.A., Kuczera, D., Brito, G.A., Bonatto, S.J., Yamazaki, R.K., Tanhoffer, R.A., et al. 2008. Beta-hydroxy-beta-methylbutyrate supplementation reduces tumor growth and tumor cell proliferation ex vivo and prevents cachexia in Walker 256 tumor-bearing rats by modifying nuclear factorkappaB expression. Nutr. Res. 28(7): 487-493. doi:10.1016/j.nutres.2008.04.006. PMID:19083450.
27. Offermanns, S. 2006. The nicotinic acid receptor GPR109A (HM74A or PUMA-G) as a new therapeutic target. Trends Pharmacol. Sci. 27(7): 384-390. doi:10.1016/j.tips.2006.05.008. PMID:16766048.
28. Palmieri, T.L., Levine, S., Schonfeld-Warden, N., O'Mara, M.S., and Greenhalgh, D.G. 2006. Hypothalamic-pituitary-adrenal axis response to sustained stress after major burn injury in children. J. Burn Care Res. 27(5): 742-748. doi:10.1097/01.BCR.0000238098.43888.07. PMID:16998409.
29. Pimentel, G.D., Rosa, J.C., Lira, F.S., Zanchi, N.E., Ropelle, E.R., Oyama, L.M., et al. 2011. beta-Hydroxy-beta-methylbutyrate (HMbeta) supplementation stimulates skeletal muscle hypertrophy in rats via the mTOR pathway. Nutr. Metab. (Lond.), 8(1): 11. doi:10.1186/1743-7075-8-11. PMID:21345206.
30. Plaisance, E.P., Lukasova, M., Offermanns, S., Zhang, Y., Cao, G., and Judd, R.L. 2009. Niacin stimulates adiponectin secretion through the GPR109A receptor. Am. J. Physiol Endocrinol Metab. 296(3): E549-E558. doi:10.1152/ajpendo.91004.2008. PMID:19141678.
31. Portal, S., Eliakim, A., Nemet, D., Halevy, O., and Zadik, Z. 2010. Effect of HMB supplementation on body composition, fitness, hormonal profile and muscle damage indices. J. Pediatr. Endocrinol. Metab. 23(7): 641-650. doi:10.1515/JPEM.2010.23.7.641. PMID:20857835.
32. Rafacho, A., Roma, L.P., Taboga, S.R., Boschero, A.C., and Bosqueiro, J.R. 2007. Dexamethasone-induced insulin resistance is associated with increased connexin 36 mRNA and protein expression in pancreatic rat islets. Can. J. Physiol. Pharmacol. 85(5): 536-545. doi:10.1139/Y07-037. PMID:17632589.
33. Rafacho, A., Giozzet, V.A., Boschero, A.C., and Bosqueiro, J.R. 2008. Functional alterations in endocrine pancreas of rats with different degrees of dexamethasone-induced insulin resistance. Pancreas, 36(3): 284-293. doi:10.1097/MPA.0b013e31815ba826. PMID:18362843.
34. Rafacho, A., Quallio, S., Ribeiro, D.L., Taboga, S.R., Paula, F.M., Boschero, A.C., et al. 2010. The adaptive compensations in endocrine pancreas from glucocorticoid-treated rats are reversible after the interruption of treatment. Acta Physiol. (Oxf.), 200(3): 223-235. doi:10.1111/j.1748-1716.2010.02146.x. PMID:20456283.
35. Rafacho, A., Abrantes, J.L., Ribeiro, D.L., Paula, F.M., Pinto, M.E., Boschero, A.C., et al. 2011. Morphofunctional alterations in endocrine pancreas of short- and long-term dexamethasone-treated rats. Horm. Metab. Res. 43(4): 275-281. doi:10.1055/s-0030-1269896. PMID:21225543.
36. Rathmacher, J.A., Nissen, S., Panton, L., Clark, R.H., Eubanks May, P., Barber, A.E., et al. 2004. Supplementation with a combination of betahydroxy- beta-methylbutyrate (HMB), arginine, and glutamine is safe and could improve hematological parameters. JPEN J. Parenter. Enteral Nutr. 28(2): 65-75. doi:10.1177/014860710402800265. PMID:15080599.
37. Santos, C.L., Rafacho, A., and Bosqueiro, J.R. 2007. Efeitos da administração de dexametasona in vivo sobre glicemia, insulinemia e substratos circulantes são dependentes do tempo de tratamento. Biosci. J. 23(3): 101-110.
38. Simmons, L.R., Molyneaux, L., Yue, D.K., and Chua, E.L. 2012. Steroid-induced diabetes: is it just unmasking of type 2 diabetes? ISRN Endocrinol. 2012, article ID 910905. doi:10.5402/2012/910905. PMID:22830041.
39. Smith, H.J., Wyke, S.M., and Tisdale, M.J. 2004. Mechanism of the attenuation of proteolysis-inducing factor stimulated protein degradation in muscle by beta-hydroxy-beta-methylbutyrate. Cancer Res. 64(23): 8731-8735. doi: 10.1158/0008-5472.CAN-04-1760. PMID:15574784.
40. Smith, H.J., Mukerji, P., and Tisdale, M.J. 2005. Attenuation of proteasomeinduced proteolysis in skeletal muscle by {beta}-hydroxy-{beta}-methylbutyrate in cancer-induced muscle loss. Cancer Res. 65(1): 277-283. PMID:15665304.
41. Vaughan, M. 1962. The production and release of glycerol by adipose tissue incubated in vitro. J. Biol. Chem. 237: 3354-3358. PMID:13996476.
42. Weir, G.C., and Bonner-Weir, S. 2004. Five stages of evolving beta-cell dysfunction during progression to diabetes. Diabetes, 53(Suppl. 3): S16-S21. doi:10.2337/diabetes.53.suppl_3.S16. PMID:15561905.
43. Wilson, J.M., Grant, S.C., Lee, S.R., Masad, I.S., Park, Y.M., Henning, et al. 2012. Beta-hydroxy-beta-methyl-butyrate blunts negative age-related changes in body composition, functionality and myofiber dimensions in rats. J. Int. Soc. Sports Nutr. 9(1): 18. doi:10.1186/1550-2783-9-18. PMID:22512917.
44. Zanchi, N.E., Gerlinger-Romero, F., Guimaraes-Ferreira, L., de Siqueira Filho, M.A., Felitti, V., Lira, F.S., et al. 2011. HMB supplementation: clinical and athletic performance-related effects and mechanisms of action. Amino Acids, 40(4): 1015-1025. doi:10.1007/s00726-010-0678-0. PMID:20607321.
45. Zanchi, N.E., Guimaraes-Ferreira, L., Siqueira-Filho, M.A., Gabriel Camporez, J.P., Nicastro, H., Seixas Chaves, D.F., et al. 2012. The possible role of leucine in modulating glucose homeostasis under distinct catabolic conditions. Med. Hypotheses, 79(6): 883-888. doi:10.1016/j.mehy.2012.09.018. PMID:23079398.